{"id":"W2593839194","doi":"10.1016/j.urolonc.2017.01.017","title":"Nivolumab treatment for advanced renal cell carcinoma: Considerations for clinical practice","year":2017,"lang":"en","type":"review","venue":"Urologic Oncology Seminars and Original Investigations","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Nivolumab; Renal cell carcinoma; Clinical Practice; Medicine; Intensive care medicine; Oncology; Cancer research; Internal medicine; Immunotherapy; Cancer; Nursing","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002106371,0.0005344636,0.001993547,0.001358956,0.0003442833,0.00207013,0.00125181,0.001749976,0.002811412],"category_scores_gemma":[0.003138141,0.0002554586,0.0009269327,0.001252253,0.0006797473,0.002108056,0.0008402293,0.003468984,0.0009526876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001324612,"about_ca_system_score_gemma":0.002894048,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001572279,"about_ca_topic_score_gemma":0.006881542,"domain_scores_codex":[0.9994853,0.0001568412,0.0001077334,0.00006642372,0.0001438305,0.00003993815],"domain_scores_gemma":[0.9984907,0.0008232426,0.0001997639,0.00002538221,0.0003746745,0.000086221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001294135,0.0000416305,0.0004182007,0.01675678,0.0001872802,0.0002682396,0.00006356392,0.0003765865,0.0004374782,0.003612306,0.05654537,0.9211633],"study_design_scores_gemma":[0.00009884358,0.0001310484,0.001172619,0.02206003,0.0004946328,0.001402318,0.0001571329,0.0002651458,0.0001918331,0.004007974,0.9699791,0.0000392593],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007506995,0.9963648,0.00008935146,0.002509523,0.0004159441,0.000003064067,0.00001126367,0.000005491363,0.0005255472],"genre_scores_gemma":[0.00159012,0.9942217,0.0004224547,0.002589013,0.0008285413,0.000009419921,0.00002551084,0.000002520977,0.0003106644],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002811412,"threshold_uncertainty_score":0.01113969,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2529915288904017,"score_gpt":0.4905502424194859,"score_spread":0.2375587135290843,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}